Published in Proc (Bayl Univ Med Cent) on July 01, 2017
Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst (1999) 8.15
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet (2005) 2.65
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst (2000) 2.41
Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol (2003) 2.29
Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci (2003) 1.28
Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat (2000) 1.09
Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Cancer (2004) 0.91
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma. Fam Cancer (2007) 0.84
Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation. Eur J Cancer Prev (2003) 0.82
Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy. J Eur Acad Dermatol Venereol (2016) 0.81
Genetic alterations in quadruple malignancies of a patient with multiple sclerosis: their role in malignancy development and response to therapy. Int J Clin Exp Pathol (2014) 0.81